Pavel Kubarkov /
29 June 2016Americas

BTG and Janssen sue Glenmark over Zytiga generic bid

BTG International and Janssen have sued Glenmark Pharmaceuticals claiming it has infringed a patent covering the Zytiga (abiraterone acetate) drug.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at